Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Midazolam vs Ketamine for Newborn Intubation
NCT01517828Phase 3Unknown
- Sponsor
- CHU Montpellier
- Start
- Jan 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in respiratory distress syndrome (RDS), sponsored by CHU Montpellier. Status: unknown.
02
Drugs
ketamine
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT01517828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01517828.